Alain Cruz-Nolasco

Dr. Alain Cruz-Nolasco

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2021 in Toxins
Verified
Journal Article
Open access
PDF file
DBDiego Becker Borin
Diego Becker Borin
KCKaren Castrejón-Arroyo
Karen Castrejón-Arroyo
ACAlain Cruz-Nolasco
Alain Cruz-Nolasco
MRMiguel Angel Peña Rico
Miguel Angel Peña Rico
MSMichele Sagrillo
Michele Sagrillo
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
The protein A13-2 was obtained from Bacillus thuringiensis strains isolated from the Papaloapan watershed region (Oaxaca, Mexico). The cytotoxic activity of parasporal inclusions was studied against breast cancer cell line (MCF-7) and normal cell (human peripheral blood mononuclear cells). The MTT, the formation of reactive species, nitric oxide, free cell DNA, and the type of death cellular were assessed. The protein A13-2 shows the highest cytotoxic activity against MCF-7 (13% cell viability at 6 µg/mL), the extracellular DNA increases, and it shows no stress for reactive species or nitric oxide. Besides, the A13-2 parasporin shows no toxicity to peripheral blood mononuclear cells, and it does not generate changes in nitric oxide levels or free cell DNA. Due to that, the cytotoxic effect of A13-2 was specific for MCF-7, and it does not affect normal cells. According to microscopy and flow cytometry, A13-2 parasporin leads to the death of MCF-7 cells by late apoptosis together with necrosis and without allowing the triggering of the survival mechanisms. When analyzed together, our results show for the first time that the A13-2 protein isolated from Mexican strains of B. thuringiensis preferentially kills MCF- 7 (cancer cells) over HEK 293 and PBMC cell lines (normal cells), thus representing a promising alternative for the treatment of cancer breast.

29 January 2026 in Molecules
Verified
Journal Article
Open access
PDF file
ACAlain Cruz-Nolasco
Alain Cruz-Nolasco
MRMiguel Angel Peña Rico
Miguel Angel Peña Rico
SESibel de Jesus Estrada Escobedo
Sibel de Jesus Estrada Escobedo
AGAngel Antonio Ortela Gregorio
Angel Antonio Ortela Gregorio
Erick Adrian Juarez-ArellanoErick Adrian Juarez-Arellano
Erick Adrian Juarez-Arellano
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
Conventional cancer therapies often harm healthy tissues due to their poor specificity, resulting in significant side effects that diminish patients’ quality of life. Parasporins, a group of non-hemolytic parasporal proteins produced by Bacillus thuringiensis, are known for their selective cytotoxicity toward cancer cells. Typically, these proteins require activation through physical or biochemical treatments that fragment them into multiple peptides of varying sizes, which are then tested as mixtures, without purification, against cancer cell lines. In this study, a purification strategy that isolates the protein without prior activation and evaluates the resulting cytotoxic mechanism is proposed. The purification consists of four steps: (1) crystal solubilization with Laemmli buffer, (2) size-based separation via SDS-PAGE, (3) electroelution of the target protein from the gel, and (4) dialysis to remove the elution buffer. From the B. thuringiensis AX isolate, four proteins ranging from ~20 to 60 kDa were recovered, but only AX-2 displayed cytotoxic activity toward MCF-7 breast cancer cells, while remaining non-hemolytic and non-toxic to normal cells (erythrocytes, PBMCs, and MRC-5 fibroblasts). Thus, AX-2 qualifies as a parasporin. AX-2 induces apoptosis in MCF-7 breast cancer cells without generating oxidative stress, and the observed cell death appears to initiate at the plasma membrane rather than through intracellular pathways.